Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-056137

SVP and General Counsel sold 2,880 shares at an average $49.78 ($143,360)

  • SVP and General Counsel acquired 2,880 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Taylor Stacy L · SVP and General Counsel

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2020-10-26 Exercise or conversion : show line 1 in the form +1,110 $7.80 $8,658 2,410 D
2020-10-26 Exercise or conversion : show line 2 in the form +1,770 $6.55 $11,594 4,180 D
2020-10-26 Sale : show line 3 in the form −618 $49.11 $30,350 3,562 D
2020-10-26 Sale : show line 4 in the form −2,262 $49.96 $113,010 1,300 D
Open-market sales · 2,880 sh · avg $49.78 · $143,360

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2020-10-26 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −1,110 35,035 D
2020-10-26 Exercise or conversion : show line 6 in the form Stock Option (Right to Buy) −1,770 30,105 D
Loading xslF345X03/doc4.xml…